Regencell Bioscience Holdings (RGC) logo

Regencell Bioscience Holdings (RGC) stock

TCM for ADHD , market cap $4.9B

$6.76
-11.86%

As of Monday's close · Live for Pro members at the open

Quality Score
-5
Poor
In its industry
#222of 291

RGC's Quality Score was unchanged on Mon, Oct 26, at -5.

See RGC's 14 chart checksSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Why is RGC down?

Down 11.9% today, more than its biotech peers' 0.8%; no story names it yet.

Fell on Oct 26

Down 12% on Oct 26.

  • Regencell Bioscience fell 12% that day while biotech stocks were flat: it trailed its group by 12 points.

No filing or headline in our sources explains it.

Sources: Price history, Oct 26, 2026

−2Long-term trend below a falling 200-day average, down over one year

The timeline and its peers, for Pro members.

Key facts on RGC

Key facts on RGC
Holding it backMoves 16.8% a day with no profit behind it
Latest filing10-Q, Oct 7 Filed its quarterly report (10-Q) for the quarter to Jun 30, 2026

3 more reasons behind RGC's -5, for Pro members.

RGC in the news

TodayNo story names it yet.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

RGC catalysts

Coming up

Here is what Pro members see.

  • The same page for Pro members, on AMD

    Its Quality Score and rank, the line that drives it, and the live price.

  • The full chart

    A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.

  • Every line of the score

    Price action, the company, and signals, each with its points, on RGC and every other stock.

  • CEOs buying their own stock

    Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.

  • Congress trades

    A member's trades, newest first, each with its amount. Sort and filter the whole list.

  • 14 chart checks, read for you

    The ones firing on the stock, each in plain words, its rule a tap away.

  • Earnings, week by week

    Who reports each day, and how each stock took its last four reports.

  • FDA dates, counted down

    Each date in the company's words, its cash against the date, and an optional alert before it.

  • The market map

    Every stock a box, colored by its Quality Score.

  • Themes, ranked live

    Each theme's stocks ranked by Quality Score, live. Here, AI chips.

  • The top 10, every day

    The ten highest Quality Scores at each close, kept day by day, week by week.

  • Optional alerts, your way

    Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.

  • Your watchlist, scored

    Your stocks by Quality Score, today's move, or name.

  • On your phone and your laptop

    The same account and watchlist on both, each laid out for its screen.

  • Prices refresh every 2.5 seconds during market hours.
  • Optional alerts by push, email, or the bell.
  • Add it to your Home Screen and it opens like an app.

RGC has 1 of 14 chart checks firing

Volume1 of 3 shown
Tight range1 of 3 shown
Buying1 of 3 shown
The other 10 checks on RGC, and all 14 on every stock.Get in free →

RGC RSI today: 42.4, above its 50-day, below its 200-day

Not scored

Not in the Quality Score: over 20 years of tests, 2006 to 2026, they added no edge.

The deep dive on RGC

5 more findings on RGC, each with its source, for Pro membersGet in free →

How RGC ranks in Biotech

RGC is #222 of 291 by Quality Score.

How RGC ranks in Biotech
222Regencell Bioscience Holdings (RGC) logoRGCRegencell Bioscience-5

Share count against a year before: RGC +0%, DFTX +30%.

More in Biotech

When does RGC report earnings, and what happens after?

Expected to report Wed Oct 28, after the close (in 2 days). Expected.

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

Everyone reporting earnings this week

RGC share count over time

Shares: about the same count as a year ago (to Jun 30).

Shares of RGC outstanding, as filed
Shares
outstanding
As
of
495.9MJun 30, 2026
494.5MJun 30, 2025
13MJun 30, 2024
13MJun 30, 2023
Offerings, shelves, and splits of RGC, from its filings
From its
filings
Filed
Registered shares for a later sale (F-3ASR)Mar 30, 2026

About Regencell Bioscience Holdings

Regencell Bioscience Holdings Ltd is an early-stage bioscience company that focuses on research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, specifically ADHD and ASD. Its goal is to save and improve the lives of patients, their families and caregivers and become a market leader for the natural and holistic treatment globally. The company operates and manages its business as a single segment - in the research and development of the company's product candidates.

10 employeesregencellbioscience.com

RGC's score card

Regencell Bioscience Holdings (RGC): Quality Score -5, Poor, #222 of 291 in Biotech, with its price, on Breakaway
The picture a link to this page shows when it is shared.

Pro members see every line of every stock's score.

  • What would turn RGC's score around: 7 things
  • 1 more filing explained, a plain line each
  • 3 more things pulling RGC's score down
See RGC's 14 chart checks

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Straight Answers

As of Oct 26, 2026: RGC's Quality Score is -5 (Poor), #222 of 291 in Biotech.

Is RGC a good stock to buy? What its Quality Score says

RGC scores -5 today, which Breakaway calls Poor. It is #222 of 291 in Biotech by Quality Score, with 1 of 14 chart checks firing. Down 12% on Oct 26. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is RGC's Quality Score?

RGC scores -5 today, which Breakaway calls Poor (below zero). That is #222 of 291 in Biotech by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind RGC's -5.

When does RGC report earnings?

Expected to report Wed Oct 28, after the close, a date Breakaway expects from the company's usual timing; the company has not confirmed it.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

The price, the score, the chart checks and readings, and the industry rank on this page are delayed at least 15 minutes.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs; recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.